115 related articles for article (PubMed ID: 33529758)
1. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
[TBL] [Abstract][Full Text] [Related]
2. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
Li X; He S; Tian Y; Weiss RM; Martin DT
Cell Signal; 2019 Nov; 63():109381. PubMed ID: 31374291
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.
Martin DT; Shen H; Steinbach-Rankins JM; Zhu X; Johnson KK; Syed J; Saltzman WM; Weiss RM
Mol Cancer Ther; 2019 Feb; 18(2):413-420. PubMed ID: 30381445
[TBL] [Abstract][Full Text] [Related]
5. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
[TBL] [Abstract][Full Text] [Related]
6. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
7. KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Yu W; Li L; Wang G; Zhang W; Xu J; Liang A
Cell Physiol Biochem; 2018; 49(6):2111-2123. PubMed ID: 30273928
[TBL] [Abstract][Full Text] [Related]
8. Effects of extremely low frequency electromagnetic field and cisplatin on mRNA levels of some DNA repair genes.
Sanie-Jahromi F; Saadat I; Saadat M
Life Sci; 2016 Dec; 166():41-45. PubMed ID: 27721000
[TBL] [Abstract][Full Text] [Related]
9. ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.
Zang Y; Pascal LE; Zhou Y; Qiu X; Wei L; Ai J; Nelson JB; Zhong M; Xue B; Wang S; Yang D; Lan L; Shan Y; Wang Z
Cancer Lett; 2018 Feb; 415():198-207. PubMed ID: 29179998
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
11. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
Xu S; Grande F; Garofalo A; Neamati N
Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
[TBL] [Abstract][Full Text] [Related]
13. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors.
Lloret M; Lara PC; Bordón E; Fontes F; Rey A; Pinar B; Falcón O
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):976-9. PubMed ID: 19251084
[TBL] [Abstract][Full Text] [Related]
14. Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells.
Wu X; Xiao H; Wang R; Liu L; Li C; Lin J
Curr Cancer Drug Targets; 2016; 16(7):631-8. PubMed ID: 26373715
[TBL] [Abstract][Full Text] [Related]
15. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
16. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
17. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
18. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks.
Wu L; Shao L; Li M; Zheng J; Wang J; Feng W; Chang J; Wang Y; Hauer-Jensen M; Zhou D
Radiat Res; 2013 Feb; 179(2):160-70. PubMed ID: 23259762
[TBL] [Abstract][Full Text] [Related]
19. Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer.
He D; Li T; Sheng M; Yang B
Med Sci Monit; 2020 Mar; 26():e918751. PubMed ID: 32167078
[TBL] [Abstract][Full Text] [Related]
20. Increased DNA double-strand break was associated with downregulation of repair and upregulation of apoptotic factors in rat hippocampus after alcohol exposure.
Suman S; Kumar S; N'Gouemo P; Datta K
Alcohol; 2016 Aug; 54():45-50. PubMed ID: 27565756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
